Carson Wealth (CWM LLC)
DMAC icon

Carson Wealth (CWM LLC)’s DiaMedica Therapeutics DMAC Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35K Buy
199
+129
+184% +$1.02K ﹤0.01% 5352
2025
Q4 		$1K Sell
70
-16
-19% -$120 ﹤0.01% 5197
2025
Q3 		$1K Buy
+86
New +$466 ﹤0.01% 5103

Other funds holding DMAC

CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Carson Wealth (CWM LLC)'s DMAC Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its DiaMedica Therapeutics (DMAC) stake by 184% in Q1 2026, buying an estimated $1.02K and bringing the position to 199 shares worth $1.35K. The position accounts for ﹤0.01% of the portfolio, ranked #5352.

Carson Wealth (CWM LLC) first reported a position in DMAC in Q3 2025 and has held it in 3 quarters since. 98 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

  • Carson Wealth (CWM LLC) held 199 shares of DiaMedica Therapeutics worth $1.35K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 129 DiaMedica Therapeutics shares in Q1 2026, an estimated $1.02K.
  • DiaMedica Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5352 holding.
  • Carson Wealth (CWM LLC) first reported a position in DiaMedica Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 98 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.